Alzheimer's Disease Trial, By Invitation (NCT07238049)

Alzheimer's Disease Trial, By Invitation NCT07238049 Sponsor: University of Oxford Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07238049 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to give your agreement to take part in the study, or if you are unable to do so yourself, someone close to you (a consultee) can advise on your behalf
You are male or female, aged 45 years or older
You have been referred to a specialist, or could be referred, because of problems with memory, thinking, or behaviour, OR you have already been diagnosed with a condition affecting your thinking — this includes people who feel their memory has changed but have no formal diagnosis, and those with functional disorders (confirm with trial site)

Who may not be able to join:

It is not possible to take a blood sample from a vein in your arm (for example, due to very poor vein access)
You are not willing to allow your information to be linked to your NHS medical records, or if you are in Northern Ireland, you are not willing to allow long-term follow-up using your electronic NHS records

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07238049

Sponsor: University of Oxford

Phase: Not Applicable

Status: By Invitation

Condition: Alzheimer's Disease

More information: https://clinicaltrials.gov/study/NCT07238049

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to give your agreement to take part in the study, or if you are unable to do so yourself, someone close to you (a consultee) can advise on your behalf
You are male or female, aged 45 years or older
You have been referred to a specialist, or could be referred, because of problems with memory, thinking, or behaviour, OR you have already been diagnosed with a condition affecting your thinking — this includes people who feel their memory has changed but have no formal diagnosis, and those with functional disorders (confirm with trial site)

Who may not be able to join:

It is not possible to take a blood sample from a vein in your arm (for example, due to very poor vein access)
You are not willing to allow your information to be linked to your NHS medical records, or if you are in Northern Ireland, you are not willing to allow long-term follow-up using your electronic NHS records

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

By Invitation

Phase

Not Applicable

Sponsor

University of Oxford

Registry

ClinicalTrials.gov

Start date

1 November 2024

Est. completion

31 October 2029

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Diagnostic accuracy of blood-based biomarkers for dementia diagnosis; Feasibility and acceptability of blood-based biomarkers for dementia diagnosis; Cost-effectiveness of blood biomarkers in a real-world cognitive disorders population

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov